Production (Stage)
BioLife Solutions, Inc.
BLFS
$21.78
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.47M | -22.24M | -49.66M | -77.09M | -54.31M |
| Total Depreciation and Amortization | 4.68M | 5.57M | 4.76M | 5.62M | 3.17M |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Other Non-Cash Items | 23.91M | 25.47M | 49.86M | 68.05M | 43.90M |
| Change in Net Operating Assets | -1.49M | -367.00K | 4.14M | 3.34M | 699.00K |
| Cash from Operations | 14.63M | 8.43M | 9.10M | -84.00K | -14.26M |
| Capital Expenditure | -1.96M | -2.35M | -3.93M | -4.78M | -5.60M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.30M | 60.65M | -7.45M | -3.26M | 11.00M |
| Cash from Investing | 31.35M | 58.30M | -11.38M | -8.04M | 14.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.40M | -6.14M | -2.53M | -242.00K | -483.00K |
| Issuance of Common Stock | 111.00K | 111.00K | 10.43M | 10.45M | 10.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -535.00K | -754.00K | -754.00K | -1.41M | -465.00K |
| Cash from Financing | -8.82M | -6.78M | 7.14M | 8.79M | 10.20M |
| Foreign Exchange rate Adjustments | 65.00K | 0.00 | 34.00K | -58.00K | -58.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.22M | 59.95M | 4.90M | 614.00K | 10.59M |